| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 245, Issue 3 294-E302, Copyright © 1983 by American Physiological Society
ARTICLES |
L. Sacca, C. Vigorito, M. Cicala, G. Corso and R. S. Sherwin
To evaluate the contribution of gluconeogenesis to epinephrine-stimulated glucose production, we infused epinephrine (0.06 micrograms X kg-1 X min-1) for 90 min into normal humans during combined hepatic vein catheterization and [U-14C]alanine infusion. Epinephrine infusion produced a rise in blood glucose (50-60%) and plasma insulin (30-40%), whereas glucagon levels increased only at 30 min (19%, P less than 0.05). Net splanchnic glucose output transiently increased by 150% and then returned to base line by 60 min. In contrast, the conversion of labeled alanine and lactate into glucose increased fourfold and remained elevated throughout the epinephrine infusion. Similarly, epinephrine produced a sustained increase in the net splanchnic uptake of cold lactate (four- to fivefold) and alanine (50-80%) although the fractional extraction of both substrates by splanchnic tissues was unchanged. We conclude that a) epinephrine is a potent stimulator of gluconeogenesis in humans, and b) this effect is primarily mediated by mobilization of lactate and alanine from extrasplanchnic tissues. Our data suggest that the initial epinephrine-induced rise in glucose production is largely due to activation of glycogenolysis. Thereafter, the effect of epinephrine on glycogenolysis (but not gluconeogenesis) wanes, and epinephrine-stimulated gluconeogenesis becomes the major factor maintaining hepatic glucose production.
This article has been cited by other articles:
|
|
 |
|
  C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Aftab Guy, D. Sandoval, M. A. Richardson, D. Tate, and S. N. Davis Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E258 - E265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Erraji-Benchekroun, D. Couton, C. Postic, I. Borde, J. Gaston, J.-G. Guillet, and C. Andre Overexpression of {beta}2-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E715 - E722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Meyer, M. Stumvoll, S. Welle, H. J. Woerle, M. Haymond, and J. Gerich Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E819 - E826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Chu, P. Galassetti, K. Igawa, D. K. Sindelar, D. W. Neal, M. Burish, and A. D. Cherrington Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E291 - E301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vicini, A. Avogaro, M. E. Spilker, A. Gallo, and C. Cobelli Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E78 - E84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lattermann, T. Schricker, U. Wachter, M. Georgieff, and A. Goertz Understanding the Mechanisms by Which Isoflurane Modifies the Hyperglycemic Response to Surgery Anesth. Analg., July 1, 2001; 93(1): 121 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zauner, B. Schneeweiss, A. Kranz, C. Madl, K. Ratheiser, L. Kramer, E. Roth, B. Schneider, and K. Lenz Resting energy expenditure in short-term starvation is increased as a result of an increase in serum norepinephrine Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1511 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Kreisman, N. A. Mew, M. Arsenault, S. J. Nessim, J. B. Halter, M. Vranic, and E. B. Marliss Epinephrine infusion during moderate intensity exercise increases glucose production and uptake Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E949 - E957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Weber and D. S. Shanghavi Regulation of glucose production in rainbow trout: role of epinephrine in vivo and in isolated hepatocytes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R956 - R963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meyer, J. Dostou, V. Nadkarni, and J. Gerich Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism Am J Physiol Renal Physiol, December 1, 1998; 275(6): F915 - F921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stumvoll, C. Meyer, G. Perriello, M. Kreider, S. Welle, and J. Gerich Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E817 - E826. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
